NIH director reportedly being tapped as acting CDC director
2026-02-18 14:13:52 ET
More on Pfizer, Johnson & Johnson, etc.
- Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game
- Pfizer: The Rebound Looks Unsustainable
- Merck: Keytruda Remains Resilient Despite LOE Risks - Buy Upon Correction
- J&J to build over $1B cell therapy production site in Pennsylvania
- AstraZeneca, Bristol partner with Evinova to use AI in drug development
Read the full article on Seeking Alpha
For further details see:
NIH director reportedly being tapped as acting CDC directorNASDAQ: MRNA
MRNA Trading
-3.49% G/L:
$52.3088 Last:
3,446,368 Volume:
$54.31 Open:



